News - Page 118 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and Advancement to First-in-Human Clinical Trial

Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and Advancement to First-in-Human Clinical Trial

Post published:March 14, 2022
Post category:Press Release

Numinus Expands Natural Psychedelic Research with New Biosecurity License

Post published:March 14, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin: Tensions Rise Among Oregon’s Psilocybin Advisory Board; Colleges Team up to Develop Psychedelic Curriculum

Psychedelic Bulletin: Tensions Rise Among Oregon’s Psilocybin Advisory Board; Colleges Team up to Develop Psychedelic Curriculum

Post published:March 11, 2022
Post category:Psychedelic Bulletin

Read more about the article Red Light Holland and Advocacy Group Psychedelic Medicine Alliance Washington Celebrate the Success of their Collaboration as Washington Legislature Funds Psilocybin Wellness Workgroup

Red Light Holland and Advocacy Group Psychedelic Medicine Alliance Washington Celebrate the Success of their Collaboration as Washington Legislature Funds Psilocybin Wellness Workgroup

Post published:March 11, 2022
Post category:Press Release

Read more about the article Small Pharma Expands Potential of Commercial Portfolio With DMT-Based Psychedelic Assets

Small Pharma Expands Potential of Commercial Portfolio With DMT-Based Psychedelic Assets

Post published:March 10, 2022
Post category:Press Release

Read more about the article Albert Labs (CSE:ABRT) Closes $4.7m Private Placement; Begins Trading on the Canadian Securities Exchange

Albert Labs (CSE:ABRT) Closes $4.7m Private Placement; Begins Trading on the Canadian Securities Exchange

Post published:March 10, 2022
Post category:Press Release

Numinus Adds Ayahuasca & San Pedro to Federal License for Psychedelic Research

Post published:March 9, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin: The Cost-Effectiveness of MDMA for PTSD; The Challenges Ahead for Psychedelic Medicine

Psychedelic Bulletin: The Cost-Effectiveness of MDMA for PTSD; The Challenges Ahead for Psychedelic Medicine

Post published:March 7, 2022
Post category:Psychedelic Bulletin

Read more about the article Psychedelic Research Bulletin: February 2022

Psychedelic Research Bulletin: February 2022

Post published:March 7, 2022
Post category:Psychedelics Research Review

Read more about the article Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care

Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care

Post published:March 3, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.